Comparison of fractional exhaled nitric oxide levels measured using the NIOX VERO and NOA 280i

Fractional exhaled nitric oxide (FeNO) is a type 2 biomarker of eosinophilic airway inflammation and predicts the likelihood of corticosteroid responsiveness in patients with eosinophilic asthma.1,2 Several devices are available to measure FeNO levels for research purposes or in clinical practice worldwide, including the Sievers Nitric Oxide Analyzer (NOA 280i; GE Analytical Instruments, Boulder, Colorado), a stationary chemiluminescence analyzer, and the NIOX VERO (Aerocrine AB, Solna, Sweden), a portable electrochemical analyzer.

http://ift.tt/2yEMSHk